VIEW THIS AS

Auto mode follows the Route Engine until you choose a viewpoint.

YOU ARE HERE

ROUTE CHECK

CONNECTED TO

WHAT NEXT

Use the canonical route for this room, or HELP if you are unsure.

Why Science? | EventPointer and Interpretable Alternative-Splicing Events

Three students sit around open books and worksheets at a classroom table, reading, writing and discussing the work together.

Science learning becomes useful when a familiar object or observation is turned into a system of quantities, mechanisms and claim limits. This guide owns one applied evidence-reading job inside eduKateSG’s wider Science estate. It connects naturally to Dexseq.Html; Why Science Deseq2 Moderated Dispersion Fold Change Count Data; Why Science Metaseqr2 Ensemble Evidence Rna Seq Workflows; Science Learning Hub; Education Hub; Careers By Subject Capability Career Pathways; How Education Works Stem Education. It also keeps current school and public claims traceable to visible primary sources: EventPointer foundational primary study; Official Bioconductor EventPointer package, release 3.23; Current official EventPointer vignette; 2026 Singapore–Cambridge O-Level Biology syllabus; MOE G2/G3 Lower Secondary Science syllabus; 2026 MOE G2 Computing syllabus. The sources describe the scientific scope; this article translates that scope into a calm route for Primary Science, PSLE Science, Secondary Science, O-Level Science, STEM exploration, school choices and career pathways without inventing admission or employment outcomes.

EventPointer is a current Bioconductor package for identifying alternative-splicing events in simple and complex designs. Its current documentation covers junction arrays and RNA-seq; for RNA-seq it can use annotated events or build a splicing graph and identify specific events. The original primary paper established the event-centred framework on junction arrays, while the current package extends the documented workflow to sequencing data. That history matters: readers should not casually attribute every current RNA-seq feature to the earlier validation study.

Inside this guide

1–12 · Foundations and models
  1. 1. Define the independent sample: Splicing Graph
  2. 2. Separate counts from molecules: Event Path
  3. 3. Write the contrast before analysis: Delta Psi
  4. 4. Name the uncertainty: Complex Design
  5. 5. State the central assumption: Novel Events
  6. 6. Keep the claim bounded: Domain Hypothesis
  7. 7. Read the official evidence in scope: Splicing Graph
  8. 8. Build a trustworthy count matrix: Event Path
  9. 9. Create a complete sample sheet: Delta Psi
  10. 10. Inspect library composition: Complex Design
  11. 11. Map sample relationships: Novel Events
  12. 12. Filter by information: Domain Hypothesis
13–24 · Evidence, testing and applications
  1. 13. Confirm the design can answer the question: Splicing Graph
  2. 14. Choose the comparison scale: Event Path
  3. 15. Practise with invented evidence: Delta Psi
  4. 16. Run the method reproducibly: Complex Design
  5. 17. Interpret the central output: Novel Events
  6. 18. Control the testing family: Domain Hypothesis
  7. 19. Read magnitude beside uncertainty: Splicing Graph
  8. 20. Plot every biological sample: Event Path
  9. 21. Inspect the decisive diagnostic: Delta Psi
  10. 22. Challenge the central assumption: Complex Design
  11. 23. Test filtering sensitivity: Novel Events
  12. 24. Test normalisation sensitivity: Domain Hypothesis
25–36 · Learning, decisions and pathways
  1. 25. Test sample influence: Splicing Graph
  2. 26. Test method settings: Event Path
  3. 27. Compare an adjacent method: Delta Psi
  4. 28. Build an evidence card: Complex Design
  5. 29. Connect to fair testing: Novel Events
  6. 30. Try a classroom investigation: Domain Hypothesis
  7. 31. Connect to mathematics: Splicing Graph
  8. 32. Connect to computing literacy: Event Path
  9. 33. Connect to education pathways: Delta Psi
  10. 34. Ask the family question: Complex Design
  11. 35. Use precise scientific language: Novel Events
  12. 36. Finish with a reproducible bundle: Domain Hypothesis

Section 1 of 36

1. Define the independent sample: Splicing Graph

Start with the experimental unit and the question. A polished differential-expression table is only as strong as the sampling design that produced its columns.

EventPointer centres the analysis on interpretable alternative-splicing events represented by paths through a splicing graph. For this method, record both the observation that supports the step and the pattern that would weaken it.

Archive counts, sample metadata, annotations, software versions, commands, filters and random seeds so another analyst can reconstruct the route from reads to claim.

Contents · Next section

Section 2 of 36

2. Separate counts from molecules: Event Path

Treat the count matrix as a chain of measurements: extraction, library construction, sequencing, alignment or quantification, annotation and summarisation all shape the number you see.

The current package documentation covers cassette exons, alternative splice sites, intron retention and other named event types. For this method, record both the observation that supports the step and the pattern that would weaken it.

Count independently collected organisms, cultures, people or specimens as biological replicates. Extra reads, lanes, re-runs and repeated software fits do not create new experimental units.

Contents · Previous section · Next section

Section 3 of 36

3. Write the contrast before analysis: Delta Psi

Write the biological comparison, reference level and covariates before opening the results. This blocks the weak habit of designing a contrast around the most colourful plot.

For RNA-seq, the package can work with annotated events or construct a splicing graph and identify events from sequencing evidence. For this method, record both the observation that supports the step and the pattern that would weaken it.

Pair adjusted evidence with direction, magnitude, uncertainty, sample-level plots and a sensitivity analysis able to contradict the headline rather than merely decorate it.

Contents · Previous section · Next section

Section 4 of 36

4. Name the uncertainty: Complex Design

Separate biological variability, sampling noise, technical processing and model uncertainty. Each enters the evidence differently and none is cancelled by a large feature list.

The package reports event identity, genomic position, statistical evidence and a change in percent spliced in where applicable. For this method, record both the observation that supports the step and the pattern that would weaken it.

Declare the tested family, planned contrasts and exclusions before highlighting genes. False-discovery control belongs to the complete decision set, not just the displayed rows.

Contents · Previous section · Next section

Section 5 of 36

5. State the central assumption: Novel Events

Name the assumption that lets the method learn across genes or samples. Once it is visible, diagnostics and sensitivity checks become purposeful rather than ritual.

A graph edge is supported by measurement and annotation choices; it is not automatically a complete transcript molecule. For this method, record both the observation that supports the step and the pattern that would weaken it.

Build an evidence card naming the question, measured material, statistical unit, model, contrast, result, alternatives, validation status and narrowest defensible claim.

Contents · Previous section · Next section

Section 6 of 36

6. Keep the claim bounded: Domain Hypothesis

Keep the conclusion at the level measured. A computational ranking can guide validation; it does not prove cellular mechanism or clinical importance.

Complex designs such as paired or time-course studies require design and contrast matrices that match the biological sampling structure. For this method, record both the observation that supports the step and the pattern that would weaken it.

Use differential expression or association when that is what was estimated. Reserve cause, mechanism, diagnosis and benefit for designs and validation that can support those stronger words.

Contents · Previous section · Next section

Section 7 of 36

7. Read the official evidence in scope: Splicing Graph

Read the primary paper beside the current official package documentation. The paper explains evaluated evidence; the package page describes the software that exists now.

The foundational paper validated the event-centred idea on junction arrays, while later package functionality includes RNA-seq; those evidence scopes must stay separate. For this method, record both the observation that supports the step and the pattern that would weaken it.

Archive counts, sample metadata, annotations, software versions, commands, filters and random seeds so another analyst can reconstruct the route from reads to claim.

Contents · Previous section · Next section

Section 8 of 36

8. Build a trustworthy count matrix: Event Path

Use documented non-negative integer counts with unique feature identifiers. Record genome and annotation releases, counting rules and strandedness so silent mismatches are discoverable.

Potential protein-domain effects are hypotheses for interpretation and follow-up, not direct protein measurements. For this method, record both the observation that supports the step and the pattern that would weaken it.

Count independently collected organisms, cultures, people or specimens as biological replicates. Extra reads, lanes, re-runs and repeated software fits do not create new experimental units.

Contents · Previous section · Next section

Section 9 of 36

9. Create a complete sample sheet: Delta Psi

Match every matrix column to one metadata row. Include condition, batch, subject, time, sex, processing order and pairing where scientifically relevant.

Novel-event discovery expands the testing universe, so annotation, filtering and multiplicity control must be reported together. For this method, record both the observation that supports the step and the pattern that would weaken it.

Pair adjusted evidence with direction, magnitude, uncertainty, sample-level plots and a sensitivity analysis able to contradict the headline rather than merely decorate it.

Contents · Previous section · Next section

Section 10 of 36

10. Inspect library composition: Complex Design

Inspect totals, detected features, zeros and dominant genes. A few abundant features can alter the comparative scale even when no code produces an error.

Percent-spliced-in change is an effect scale; its uncertainty and sample-level consistency matter beside a threshold. For this method, record both the observation that supports the step and the pattern that would weaken it.

Declare the tested family, planned contrasts and exclusions before highlighting genes. False-discovery control belongs to the complete decision set, not just the displayed rows.

Contents · Previous section · Next section

Section 11 of 36

11. Map sample relationships: Novel Events

Use ordination, correlations and sample-distance views as questions, not verdicts. Investigate surprising clusters against provenance before excluding any observation.

Event-level methods help readers ask a concrete structural question rather than treating every transcript label as equally identifiable. For this method, record both the observation that supports the step and the pattern that would weaken it.

Build an evidence card naming the question, measured material, statistical unit, model, contrast, result, alternatives, validation status and narrowest defensible claim.

Contents · Previous section · Next section

Section 12 of 36

12. Filter by information: Domain Hypothesis

Apply a declared information filter before testing and preserve the retained universe. Filtering changes estimation and the number of decisions receiving multiplicity correction.

Orthogonal validation may use targeted RT-PCR, long-read sequencing or protein assays according to the ambiguity that remains. For this method, record both the observation that supports the step and the pattern that would weaken it.

Use differential expression or association when that is what was estimated. Reserve cause, mechanism, diagnosis and benefit for designs and validation that can support those stronger words.

Contents · Previous section · Next section

Section 13 of 36

13. Confirm the design can answer the question: Splicing Graph

Check that the design matrix has independent information for every requested effect. Perfect condition–batch confounding has no unique statistical solution.

EventPointer centres the analysis on interpretable alternative-splicing events represented by paths through a splicing graph. For this method, record both the observation that supports the step and the pattern that would weaken it.

Archive counts, sample metadata, annotations, software versions, commands, filters and random seeds so another analyst can reconstruct the route from reads to claim.

Contents · Previous section · Next section

Section 14 of 36

14. Choose the comparison scale: Event Path

Choose scaling and offsets from biology and diagnostics rather than the number of discoveries. Save the factors because they are part of the evidence.

The current package documentation covers cassette exons, alternative splice sites, intron retention and other named event types. For this method, record both the observation that supports the step and the pattern that would weaken it.

Count independently collected organisms, cultures, people or specimens as biological replicates. Extra reads, lanes, re-runs and repeated software fits do not create new experimental units.

Contents · Previous section · Next section

Section 15 of 36

15. Practise with invented evidence: Delta Psi

The table below is a fictional classroom example, visibly labelled so it cannot be mistaken for a study result.

Fictional eventEvent typeDelta PSIAdjusted p-valueReading
EVT-17Cassette exon+0.210.018Supported event change
EVT-29Alternative 3′ site-0.050.420Weak evidence
EVT-44Intron retention+0.160.047Validate independently
Invented classroom data for comparison practice; not an operational, product-certification or safety dataset.

For RNA-seq, the package can work with annotated events or construct a splicing graph and identify events from sequencing evidence. Pair adjusted evidence with direction, magnitude, uncertainty, sample-level plots and a sensitivity analysis able to contradict the headline rather than merely decorate it.

Contents · Previous section · Next section

Section 16 of 36

16. Run the method reproducibly: Complex Design

Record the package release, function calls, arguments, factor levels and seeds. A reproducible command history is a scientific explanation another analyst can challenge.

The package reports event identity, genomic position, statistical evidence and a change in percent spliced in where applicable. For this method, record both the observation that supports the step and the pattern that would weaken it.

Declare the tested family, planned contrasts and exclusions before highlighting genes. False-discovery control belongs to the complete decision set, not just the displayed rows.

Contents · Previous section · Next section

Section 17 of 36

17. Interpret the central output: Novel Events

Read the method-specific statistic together with its sign and units. Confirm which level is the reference before writing increase or decrease.

A graph edge is supported by measurement and annotation choices; it is not automatically a complete transcript molecule. For this method, record both the observation that supports the step and the pattern that would weaken it.

Build an evidence card naming the question, measured material, statistical unit, model, contrast, result, alternatives, validation status and narrowest defensible claim.

Contents · Previous section · Next section

Section 18 of 36

18. Control the testing family: Domain Hypothesis

Control false discoveries across all genes and planned contrasts. A threshold selected after browsing the ranking is not a prespecified decision rule.

Complex designs such as paired or time-course studies require design and contrast matrices that match the biological sampling structure. For this method, record both the observation that supports the step and the pattern that would weaken it.

Use differential expression or association when that is what was estimated. Reserve cause, mechanism, diagnosis and benefit for designs and validation that can support those stronger words.

Contents · Previous section · Next section

Section 19 of 36

19. Read magnitude beside uncertainty: Splicing Graph

Show fold change or another effect beside adjusted evidence and uncertainty. Statistical detectability and biological importance are not synonyms.

The foundational paper validated the event-centred idea on junction arrays, while later package functionality includes RNA-seq; those evidence scopes must stay separate. For this method, record both the observation that supports the step and the pattern that would weaken it.

Archive counts, sample metadata, annotations, software versions, commands, filters and random seeds so another analyst can reconstruct the route from reads to claim.

Contents · Previous section · Next section

Section 20 of 36

20. Plot every biological sample: Event Path

Plot every independent sample behind each headline feature. Means and model lines can hide outliers, inconsistent direction and sparse support.

Potential protein-domain effects are hypotheses for interpretation and follow-up, not direct protein measurements. For this method, record both the observation that supports the step and the pattern that would weaken it.

Count independently collected organisms, cultures, people or specimens as biological replicates. Extra reads, lanes, re-runs and repeated software fits do not create new experimental units.

Contents · Previous section · Next section

Section 21 of 36

21. Inspect the decisive diagnostic: Delta Psi

Choose a diagnostic that attacks the method’s defining assumption. A dashboard is useful only when each panel can change a decision.

Novel-event discovery expands the testing universe, so annotation, filtering and multiplicity control must be reported together. For this method, record both the observation that supports the step and the pattern that would weaken it.

Pair adjusted evidence with direction, magnitude, uncertainty, sample-level plots and a sensitivity analysis able to contradict the headline rather than merely decorate it.

Contents · Previous section · Next section

Section 22 of 36

22. Challenge the central assumption: Complex Design

Ask what pattern would make the core assumption false, then look for it. Scientific confidence grows from surviving serious alternatives, not repeating one fit.

Percent-spliced-in change is an effect scale; its uncertainty and sample-level consistency matter beside a threshold. For this method, record both the observation that supports the step and the pattern that would weaken it.

Declare the tested family, planned contrasts and exclusions before highlighting genes. False-discovery control belongs to the complete decision set, not just the displayed rows.

Contents · Previous section · Next section

Section 23 of 36

23. Test filtering sensitivity: Novel Events

Repeat a small set of defensible count filters and record changes in sign, rank and adjusted evidence.

Event-level methods help readers ask a concrete structural question rather than treating every transcript label as equally identifiable. For this method, record both the observation that supports the step and the pattern that would weaken it.

Build an evidence card naming the question, measured material, statistical unit, model, contrast, result, alternatives, validation status and narrowest defensible claim.

Contents · Previous section · Next section

Section 24 of 36

24. Test normalisation sensitivity: Domain Hypothesis

Compare justified normalisation choices with the same samples, feature universe and contrast. Explain consequential reversals rather than hiding them.

Orthogonal validation may use targeted RT-PCR, long-read sequencing or protein assays according to the ambiguity that remains. For this method, record both the observation that supports the step and the pattern that would weaken it.

Use differential expression or association when that is what was estimated. Reserve cause, mechanism, diagnosis and benefit for designs and validation that can support those stronger words.

Contents · Previous section · Next section

Section 25 of 36

25. Test sample influence: Splicing Graph

Where replication permits, leave out one biological sample at a time. A discovery that disappears with one sample needs narrower language.

EventPointer centres the analysis on interpretable alternative-splicing events represented by paths through a splicing graph. For this method, record both the observation that supports the step and the pattern that would weaken it.

Archive counts, sample metadata, annotations, software versions, commands, filters and random seeds so another analyst can reconstruct the route from reads to claim.

Contents · Previous section · Next section

Section 26 of 36

26. Test method settings: Event Path

Vary only settings supported by the documentation and question. Do not tune until a preferred gene crosses a threshold.

The current package documentation covers cassette exons, alternative splice sites, intron retention and other named event types. For this method, record both the observation that supports the step and the pattern that would weaken it.

Count independently collected organisms, cultures, people or specimens as biological replicates. Extra reads, lanes, re-runs and repeated software fits do not create new experimental units.

Contents · Previous section · Next section

Section 27 of 36

27. Compare an adjacent method: Delta Psi

Compare an adjacent method after aligning inputs and contrasts. Differences are clues about assumptions, not an automatic contest with one universal winner.

For RNA-seq, the package can work with annotated events or construct a splicing graph and identify events from sequencing evidence. For this method, record both the observation that supports the step and the pattern that would weaken it.

Pair adjusted evidence with direction, magnitude, uncertainty, sample-level plots and a sensitivity analysis able to contradict the headline rather than merely decorate it.

Contents · Previous section · Next section

Section 28 of 36

28. Build an evidence card: Complex Design

Summarise provenance, design, preprocessing, model, estimate, uncertainty, diagnostics, sensitivities and validation in one compact evidence card.

The package reports event identity, genomic position, statistical evidence and a change in percent spliced in where applicable. For this method, record both the observation that supports the step and the pattern that would weaken it.

Declare the tested family, planned contrasts and exclusions before highlighting genes. False-discovery control belongs to the complete decision set, not just the displayed rows.

Contents · Previous section · Next section

Section 29 of 36

29. Connect to fair testing: Novel Events

This is the same logic as a fair school experiment: control what can be controlled, record what cannot, repeat independent units and separate observation from explanation.

A graph edge is supported by measurement and annotation choices; it is not automatically a complete transcript molecule. For this method, record both the observation that supports the step and the pattern that would weaken it.

Build an evidence card naming the question, measured material, statistical unit, model, contrast, result, alternatives, validation status and narrowest defensible claim.

Contents · Previous section · Next section

Section 30 of 36

30. Try a classroom investigation: Domain Hypothesis

A safe classroom model can make the invisible assumption tangible without pretending to reproduce a laboratory sequencing experiment.

Draw a three-node splicing graph with two possible paths. Give each group fictional junction counts, ask them to estimate which path becomes more common, and list the evidence a graph alone cannot provide. The activity is a learning model, not an RNA-seq experiment, diagnostic test or health claim.

Complex designs such as paired or time-course studies require design and contrast matrices that match the biological sampling structure. Use differential expression or association when that is what was estimated. Reserve cause, mechanism, diagnosis and benefit for designs and validation that can support those stronger words.

Contents · Previous section · Next section

Section 31 of 36

31. Connect to mathematics: Splicing Graph

Ratios, logarithms, distributions, smoothing, shrinkage and multiple-testing correction turn a biological question into quantities that can be checked.

The foundational paper validated the event-centred idea on junction arrays, while later package functionality includes RNA-seq; those evidence scopes must stay separate. For this method, record both the observation that supports the step and the pattern that would weaken it.

Archive counts, sample metadata, annotations, software versions, commands, filters and random seeds so another analyst can reconstruct the route from reads to claim.

Contents · Previous section · Next section

Section 32 of 36

32. Connect to computing literacy: Event Path

Scripts make identifiers, filters, factor levels and versions inspectable. Computing literacy means understanding how code changes the claim, not merely making code run.

Potential protein-domain effects are hypotheses for interpretation and follow-up, not direct protein measurements. For this method, record both the observation that supports the step and the pattern that would weaken it.

Count independently collected organisms, cultures, people or specimens as biological replicates. Extra reads, lanes, re-runs and repeated software fits do not create new experimental units.

Contents · Previous section · Next section

Section 33 of 36

33. Connect to education pathways: Delta Psi

RNA-seq connects biology, statistics and computing. It can illuminate study routes in life science, biotechnology and data analysis without promising admission or a career outcome.

Novel-event discovery expands the testing universe, so annotation, filtering and multiplicity control must be reported together. For this method, record both the observation that supports the step and the pattern that would weaken it.

Pair adjusted evidence with direction, magnitude, uncertainty, sample-level plots and a sensitivity analysis able to contradict the headline rather than merely decorate it.

Contents · Previous section · Next section

Section 34 of 36

34. Ask the family question: Complex Design

A useful family question is simple: how many independent biological samples support this result, and which assumption most affects the ranking?

Percent-spliced-in change is an effect scale; its uncertainty and sample-level consistency matter beside a threshold. For this method, record both the observation that supports the step and the pattern that would weaken it.

Declare the tested family, planned contrasts and exclusions before highlighting genes. False-discovery control belongs to the complete decision set, not just the displayed rows.

Contents · Previous section · Next section

Section 35 of 36

35. Use precise scientific language: Novel Events

Write that the analysis supports differential expression or an association under the stated design and method. Avoid cause, cure, diagnosis or mechanism unless separate evidence justifies them.

Event-level methods help readers ask a concrete structural question rather than treating every transcript label as equally identifiable. For this method, record both the observation that supports the step and the pattern that would weaken it.

Build an evidence card naming the question, measured material, statistical unit, model, contrast, result, alternatives, validation status and narrowest defensible claim.

Contents · Previous section · Next section

Section 36 of 36

36. Finish with a reproducible bundle: Domain Hypothesis

Deliver counts or stable accessions, metadata, annotations, code, settings, complete results, plots, sensitivity analyses, package versions and the narrowest defensible interpretation.

Orthogonal validation may use targeted RT-PCR, long-read sequencing or protein assays according to the ambiguity that remains. For this method, record both the observation that supports the step and the pattern that would weaken it.

Use differential expression or association when that is what was estimated. Reserve cause, mechanism, diagnosis and benefit for designs and validation that can support those stronger words.

Source date and scope note

Primary studies and current official software documentation were checked for this article on 11 October 2026. Package interfaces, dependencies and recommendations can change; consult the linked current release page and guide before reproduction.

Did You Know?

Two analyses can use the same RNA-seq samples yet ask different questions: total gene abundance, relative exon usage, a named splicing event, a time-course profile or a variance-component association. Scientific literacy begins by naming the question before comparing the answers.

Final reader checklist

Confirm the independent biological sample count, design, measured material, annotation, preprocessing, statistical unit, exact contrast, effect scale, uncertainty, controls, sensitivity checks, validation plan and the boundary between association and causation.

Contents · Previous section · Continue to the Science Learning Hub

Discover more from eduKate Singapore

Subscribe now to keep reading and get access to the full archive.

Continue reading